Laurus Labs Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹1,778.29 crore, reflecting a quarter-on-quarter *(QoQ) increase of 7.55 per cent from ₹1,653.47 crore. This corresponds to a year-on-year *(YoY) growth of 25.67 per cent.
Operating Profit
Operating Profit stands at ₹44.55 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 33.47 per cent from ₹66.96 crore. This corresponds to a year-on-year *(YoY) decline of 33.73 per cent.
PBDT
PBDT stands at ₹194.07 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 1.22 per cent from ₹196.47 crore. This corresponds to a year-on-year *(YoY) growth of 32.78 per cent.
Profit Before Tax
Profit Before Tax stands at ₹325.33 crore, reflecting a quarter-on-quarter *(QoQ) increase of 20.28 per cent from ₹270.47 crore. This corresponds to a year-on-year *(YoY) growth of 144.59 per cent.
Net Profit
Net Profit stands at ₹251.66 crore, reflecting a quarter-on-quarter *(QoQ) increase of 29.08 per cent from ₹194.97 crore. This represents a 172.65 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Laurus Labs Ltd News
Laurus Labs Ltd Earnings
- YOY
- QOQ
Laurus Labs Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Laurus Labs Ltd Research Reports
Laurus Labs Ltd Financial Reports
Laurus Labs Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Laurus Labs | -3.03% | -4.54% | -10.98% | 0.10% | 10.13% | 65.11% |
| Biocon | -1.92% | -0.90% | -6.99% | -3.69% | -8.61% | 1.67% |
| Abbott India | -3.42% | -4.24% | -6.52% | -10.07% | -24.27% | 2.13% |
| Glenmark Pharma. | -0.85% | 0.57% | -2.35% | 5.22% | -8.04% | 36.75% |
| Glaxosmi. Pharma | -3.35% | 1.93% | -1.39% | -10.05% | -26.25% | 18.92% |
| Ipca Labs. | 1.84% | 0.55% | 6.01% | 14.15% | -3.81% | 1.07% |
| Ajanta Pharma | -0.34% | -0.10% | -1.03% | 9.24% | -3.70% | 0.79% |
Company Info
Company Information
Executive Director & CEO : CHAVA SATYANARAYANA
Executive Director & CFO : VENKATA RAVI KUMAR VANTARAM
Executive Director : Chandrakanth Chereddi
Director : Narendra Ostawal
Independent Director : Aruna Bhinge
Independent Director : Rajesh Koshy Chandy
Independent Director : Ramesh Subrahmanian
Company Secretary : G Venkateswar Reddy
Chairman : M Venu Gopala Rao
Independent Director : Ravindranath Kancherla
Executive Director : Venkata Lakshmana Rao Chunduru